Company: RVRC
Filing Date: 2025-10-03
Form Type: S-1/A
Source: 0001213900-25-096094
Chunk: 63

Company: Revium Rx.
Filing Date: 2025-10-03
Form: S-1/A
Chunk 63
---
of potential uses, including areas with high unmet-needs such as antimicrobial resistance and solid tumors. Our planned clinical trials
aim to expand the therapeutic horizons of hard-to-treat diseases by amplifying, improving, and unleashing the potential of encapsulated
therapeutics to enhance delivery and achieve a controlled release. This includes antimicrobial resistance and solid tumors being as they
are areas with high unmet need.

We were incorporated on January 24, 1997 as a
Delaware corporation under the name “Fun Cosmetic, Inc.” On August 29, 2005, it changed its name to Grand Canal Entertainment,
Inc. On October 14, 2008, the Company merged with OC Beverage, Inc. a Nevada corporation, a manufacturer of beverages, and on October
31, 2008 it subsequently changed its name to OC Beverages, Inc. It ceased operations as a manufacturer of beverages in 2010. On June
22, 2020, the Company formed a wholly owned Israeli subsidiary called Revium Recovery Ltd. On December 4, 2020, the Company changed its
name to Revium Recovery Inc.

On December 17, 2024, the Company completed the
redomicile from the State of Delaware to the State of Nevada by conversion (the “Reincorporation”), pursuant to the Plan
of Conversion dated December 16, 2024. As a result of the Reincorporation, the Company ceased continued its business existence as a Nevada
corporation under the name “Revium Rx.” succeeding all our rights, assets, liabilities and obligations, except that our affairs
ceased to be governed by the Delaware General Corporation Law, the Certificate of Incorporation, as amended, and became subject to the
Nevada Revised Statutes, Articles of Incorporation and our new bylaws subject to the Nevada Revised Statutes. The Reincorporation did
not change the number of the authorized shares of the Company, its par value, or its issued and outstanding shares. Additionally, on
March 3, 2025, the corporate name of Revium Recovery Ltd., our subsidiary, was changed to “Revium RX Ltd.”

On July 23, 2024, we consummated the Share
Exchange contemplated by the Stock Exchange Agreement, dated November 14, 2023 (the “Share Exchange Agreement”), by and among
the Company, LipoVation Ltd., a company organized under the laws of the State of